Thirty-day survival and the prognostic indicators on univariate analysis in 358 patients with newly diagnosed APL. (A) Thirty-day survival in 358 patients with newly diagnosed APL. Impact of sex (B), age (C), WBC count (D), presenting PT (E), presenting APTT (F), presenting fibrinogen level (G), and timing of ATRA administration (H) on 30-day survival.